WILHELMUS CM GROENHUYSEN Insider Trading
Get free email notifications about insider trading for WILHELMUS CM GROENHUYSEN.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of WILHELMUS CM GROENHUYSEN. WILHELMUS CM GROENHUYSEN is a Director in NAVTEQ CORP ($NVT) and a Director in OptiNose, Inc. ($OPTN) and a CFO in NovoCure Ltd ($NVCR) and a Chief Financial Officer in Novocure Ltd ($NVCR) and a Chief Operating Officer in NovoCure Ltd ($NVCR).
Address: C/O NAVTEQ CORPORATION 222 MERCHANDISE MART, SUITE 900 CHICAGO 60654 IL
Companies in which WILHELMUS CM GROENHUYSEN is an Insider
NAVTEQ CORP
Trading Symbol: NVTIndustry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of WILHELMUS CM GROENHUYSEN: Director
Holdings: 1,500 shares
Latest Transaction: Aug 10 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NovoCure Ltd
Trading Symbol: NVCRIndustry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of WILHELMUS CM GROENHUYSEN: Chief Operating Officer, CFO, Chief Financial Officer
Holdings: 150,014 shares
Current Value: $1,020,095
Latest Transaction: Apr 08 2021
$NVCR Market Capitalization: $581.43M
$NVCR Previous Close: $6.80
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
OptiNose, Inc.
Trading Symbol: OPTNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of WILHELMUS CM GROENHUYSEN: Director
Holdings: 0 shares
Latest Transaction: Jun 12 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of WILHELMUS CM GROENHUYSEN
Sentiment: All, NVT, NVCR, OPTN
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 08 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 72.22 | 3,670 | 265,029 | 150,014 | 153.7 K to 150 K (-2.39 %) |
Mar 10 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 130.81 | 3,004 | 392,941 | 153,684 | 156.7 K to 153.7 K (-1.92 %) |
Mar 08 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 137.55 | 3,854 | 530,133 | 156,688 | 160.5 K to 156.7 K (-2.40 %) |
Mar 04 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | A | 153.09 | 23,004 | 3,521,682 | 23,004 | |
Mar 04 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Grant | A | 0.00 | 12,519 | 0 | 160,542 | 148 K to 160.5 K (+8.46 %) |
Mar 04 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Sell | S | 152.05 | 2,392 | 363,711 | 148,023 | 150.4 K to 148 K (-1.59 %) |
Mar 02 2021 | NVCR | NovoCure Ltd | GROENHUYSEN WILHELMUS CM | Chief Operating Off ... | Option Exercise | M | 0.00 | 7,715 | 0 | 0 |